Bovine serum albumin (BSA) is a protein derived from cows that has wide application in life sciences research and biotechnology industries. As a blood derivative, BSA plays a critical role as a protein standard and blocking agent in techniques like enzyme-linked immunosorbent assay (ELISA), western blotting and immunohistochemistry. It is commonly used as a stabilizing agent to prevent aggregation of antibodies and peptides. Due to its affordability and consistency between batches, BSA has become a laboratory workhorse helping scientists across proteomics and molecular biology domains.
Market Dynamics:
Global bovine serum albumin market growth is primarily driven by rising R&D spending on proteomics and biopharmaceuticals. BSA is used as a stabilizer in protein formulation throughout the biologics manufacturing lifecycle. Increasing focus on early-stage drug discovery and cell culture research supported by growing funding has boosted sales. However, availability of alternative products like fetal bovine serum and human serum albumin can hamper the market growth. Stringent regulatory norms also add to compliance burden. Production expansion efforts by key players to meet burgeoning requirements from academia and research institutes provide lucrative opportunities for market players.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook